how the mpn field has evolved over the years: novel agents, trials, and more
Published 1 year ago • 172 plays • Length 2:06Download video MP4
Download video MP3
Similar videos
-
3:05
recent updates in the mpn field: clinical trials, novel agents, and more
-
1:31
novel treatment agents and how they're changing the mpn field
-
1:26
current and emerging prognostic factors for mds/mpn
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:44
upcoming trials and novel agents in mpns
-
16:35
key highlights in mpns at ash 2023: novel agents & combinations, ongoing clinical trials, and more
-
3:51
কিভাবে থ্যালাসেমিয়ায় আক্রান্ত রোগীকে শনাক্ত করা হয়? | thalassemia | health | channel 24
-
9:25
mgus diagnosis: a step-by-step approach
-
5:00
diagnosing and treating al amyloidosis: a 2020 update from dr morie gertz
-
0:50
update on the pimms trial of ivosidenib for patients with idh1-mutated ccus
-
1:13
ongoing trials in wm, where the field is moving, and the growing role of novel agents
-
0:47
novel agents being explored for the treatment of immune-mediated ttp
-
2:28
how to approach the treatment of younger patients with mpn
-
0:55
a pooled analysis to determine the optimal ki-67 index cut-off point for predicting outcomes in mcl
-
1:30
advancements in prognostication tools in mpns in recent years
-
2:43
the management of advanced phase mpns
-
2:21
the current state of the art in all and how novel agents are impacting the field
-
4:27
insights into a novel murine model being used to investigate the pathophysiology of icans
-
1:05
moving the mpn field forward
-
2:06
understanding the role of inflammation and the immunome in mds pathophysiology
-
1:07
the second revision of the international staging system for os in mm